Mansoor Saleh, MD began his early education in the Aga Khan School system in East Africa and pursued his medical degree at the University of Heidelberg in Germany. He completed his doctoral research at the prestigious Max Planck Institute for Medical Research in Heidelberg. Dr. Saleh went on to receive his internal medicine training at Henry Ford Hospital in Detroit, Michigan, followed by subspecialty training in Hematology and Oncology at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center.
At UAB, he served as a tenured Professor of Medicine and Pathology and was the Director of the First-in-Human Early Drug Development Program. His research and clinical work have centred on the targeted therapy of cancer, with a strong focus on translating novel agents from bench to bedside.
In January 2020, Dr. Saleh returned to East Africa to join the Aga Khan University in Nairobi, Kenya, where he currently serves as the Founding Chair of the Department of Hematology-Oncology and Founding Director of the AKU-Nairobi Cancer Center.
Mansoor Saleh, MD earned his medical degree from the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research. He trained in internal medicine at Henry Ford Hospital in Detroit and completed his Hematology-Oncology fellowship at the University of Alabama at Birmingham (UAB), where he became a tenured Professor and Director of the First-in-Human Early Drug Development Program. His research focuses on targeted cancer therapies and translational oncology. In 2020, he joined Aga Khan University in Nairobi as Founding Chair of Hematology-Oncology and Founding Director of the University’s Cancer Center.